Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12,962	10,139	14,927	10,696	6,137	5,639
Short-Term Investments	4,600	7,500	-	3,000	7,000	6,500
Cash & Short-Term Investments	17,562	17,639	14,927	13,696	13,137	12,139
Cash Growth	11.38%	18.17%	8.99%	4.25%	8.22%	-12.66%
Accounts Receivable	2,529	2,855	2,667	1,451	2,130	1,274
Other Receivables	181.8	96.37	55.64	17.55	293.91	219.34
Receivables	2,791	3,331	2,723	1,469	2,424	1,494
Inventory	4,594	4,198	3,852	3,759	2,353	2,110
Prepaid Expenses	120.6	130.07	13.01	343.11	58.1	70.99
Other Current Assets	182.47	268.1	88.1	284.98	413.05	128.57
Total Current Assets	25,251	25,567	21,603	19,552	18,386	15,942
Property, Plant & Equipment	7,843	7,770	8,035	7,285	5,776	1,673
Long-Term Investments	8,058	8,058	8,584	7,233	7,744	6,986
Other Intangible Assets	140.43	131.53	31.03	64.35	101.08	152.42
Long-Term Deferred Tax Assets	1,761	1,842	2,064	2,043	1,780	-
Long-Term Deferred Charges	-	-	-	-	0	71.52
Other Long-Term Assets	863.55	858.17	600.51	723.89	683.35	656.94
Total Assets	43,964	44,275	40,932	36,901	34,469	25,481
Accounts Payable	373.81	97.48	164.9	134.26	144.46	278.44
Accrued Expenses	58.71	234.02	130.05	277.79	150.37	143.95
Current Portion of Long-Term Debt	-	-	3,900	-	-	-
Current Portion of Leases	169.96	173.94	175.47	235.32	214.76	211.59
Current Income Taxes Payable	101.67	79.88	77.4	87.32	-	-
Current Unearned Revenue	-	-	9.86	-	-	-
Other Current Liabilities	1,013	1,311	780.35	598.52	907.73	585.46
Total Current Liabilities	1,717	1,896	5,238	1,333	1,417	1,219
Long-Term Debt	2,400	2,400	-	3,900	3,900	-
Long-Term Leases	342.31	389.6	587.61	243.97	320.97	916.77
Other Long-Term Liabilities	425.81	335.45	284.31	152.49	98.52	270.52
Total Liabilities	8,801	8,781	9,620	8,052	7,477	4,017
Common Stock	7,189	7,189	7,189	3,595	3,595	3,595
Additional Paid-In Capital	22,646	22,646	22,646	26,259	26,259	26,259
Retained Earnings	6,405	5,851	1,680	-1,202	-2,936	-8,449
Comprehensive Income & Other	-217.59	-191.59	-203.85	197.9	74.85	59.14
Shareholders' Equity	35,163	35,494	31,311	28,850	26,992	21,464
Total Liabilities & Equity	43,964	44,275	40,932	36,901	34,469	25,481
Total Debt	2,912	2,964	4,663	4,379	4,436	1,128
Net Cash (Debt)	14,650	14,676	10,264	9,317	8,701	11,010
Net Cash Growth	31.34%	42.98%	10.17%	7.07%	-20.97%	-12.74%
Net Cash Per Share	1020.70	1020.63	713.81	647.93	605.15	1058.68
Filing Date Shares Outstanding	14.1	14.38	14.38	14.38	14.38	14.38
Total Common Shares Outstanding	14.1	14.38	14.38	14.38	14.38	14.38
Working Capital	23,533	23,671	16,365	18,219	16,968	14,722
Book Value Per Share	2493.43	2468.50	2177.60	2006.39	1877.21	1492.72
Tangible Book Value	35,022	35,363	31,280	28,785	26,891	21,311
Tangible Book Value Per Share	2483.48	2459.36	2175.44	2001.92	1870.18	1482.12
Land	1,557	1,557	1,557	-	1,557	-
Buildings	2,974	2,974	2,974	-	2,974	-
Machinery	2,752	2,734	2,502	-	2,001	1,780
Construction In Progress	2,527	2,338	2,278	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.